|
|
||||||||

*
Department of Pediatrics and Clinical Immunology, Mie University School of Medicine, Tsu, Mie, Japan; and
Department of Pediatrics, National Mie Chuo Hospital, Tsu, Mie, Japan
Dendritic cell (DC) is the most potent activator of
CD4+ T cells and has unique dendrites and veils. To explore
the function of Rho in DC, exoenzyme C3 from Clostridium
botulinum was used as a specific inhibitor of Rho. Treatment of
DC with C3 (DC/C3) resulted in profound morphological changes by losing
dendrites and emerging of shrunk membrane processes that were in
parallel with marked reduction of polymerized actin in the marginal
area. Inactivation of Rho-associated coiled coil-containing kinase
(p160ROCK) by a specific ROCK inhibitor Y-27632 also led to
disappearance of dendrites of DC with retaining large membrane
expansions. In scanning electron microscopy, untreated DCs interacted
with CD4+ T cells more efficiently than DC/C3. Conjugate
formation assay showed that the number of DCs associated with
CD4+ T cells was 2-fold higher in untreated DCs than that
of DC/C3. Alloantigen-presenting capacity of DC/C3 was significantly
suppressed in a dose-dependent manner. Because C3 treatment did not
affect the surface expression of HLA, costimulatory, and adhesion
molecules of DC, we examined cytokine production of DC and naive
CD4+ T cells to further elucidate the inhibitory mechanism
of MLR. Unexpectedly, DC/C3 increased IL-12 production after LPS
stimulation. Naive CD4+ T cells cocultured with DC/C3
produced the increased percentage of IFN-
-producing cells, whereas
the percentage of IL-2-producing T cells was decreased. These results
demonstrate that Rho GTPase in DC controls both characteristic shape
and immunogenic capacity.
This article has been cited by other articles:
![]() |
D. Schaafsma, I. S. T. Bos, A. B. Zuidhof, J. Zaagsma, and H. Meurs The inhaled Rho kinase inhibitor Y-27632 protects against allergen-induced acute bronchoconstriction, airway hyperresponsiveness, and inflammation Am J Physiol Lung Cell Mol Physiol, July 1, 2008; 295(1): L214 - L219. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Czeloth, A. Schippers, N. Wagner, W. Muller, B. Kuster, G. Bernhardt, and R. Forster Sphingosine-1 Phosphate Signaling Regulates Positioning of Dendritic Cells within the Spleen J. Immunol., November 1, 2007; 179(9): 5855 - 5863. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Tourkova, G. V. Shurin, S. Wei, and M. R. Shurin Small Rho GTPases Mediate Tumor-Induced Inhibition of Endocytic Activity of Dendritic Cells J. Immunol., June 15, 2007; 178(12): 7787 - 7793. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sanchez-Sanchez, L. Riol-Blanco, and J. L. Rodriguez-Fernandez The Multiple Personalities of the Chemokine Receptor CCR7 in Dendritic Cells J. Immunol., May 1, 2006; 176(9): 5153 - 5159. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ahn and B. Agrawal IL-4 is more effective than IL-13 for in vitro differentiation of dendritic cells from peripheral blood mononuclear cells Int. Immunol., October 1, 2005; 17(10): 1337 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. V. Shurin, I. L. Tourkova, G. S. Chatta, G. Schmidt, S. Wei, J. Y. Djeu, and M. R. Shurin Small Rho GTPases Regulate Antigen Presentation in Dendritic Cells J. Immunol., March 15, 2005; 174(6): 3394 - 3400. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, S. N. Sait, and M. Wetzler Characterization of dendritic-like cells derived from t(9;22) acute lymphoblastic leukemia blasts Int. Immunol., October 1, 2004; 16(10): 1377 - 1389. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Benvenuti, S. Hugues, M. Walmsley, S. Ruf, L. Fetler, M. Popoff, V. L. J. Tybulewicz, and S. Amigorena Requirement of Rac1 and Rac2 Expression by Mature Dendritic Cells for T Cell Priming Science, August 20, 2004; 305(5687): 1150 - 1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jaksits, W. Bauer, E. Kriehuber, M. Zeyda, T. M. Stulnig, G. Stingl, E. Fiebiger, and D. Maurer Lipid Raft-Associated GTPase Signaling Controls Morphology and CD8+ T Cell Stimulatory Capacity of Human Dendritic Cells J. Immunol., August 1, 2004; 173(3): 1628 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jiang, C. Van de Ven, P. Satwani, L. V. Baxi, and M. S. Cairo Differential Gene Expression Patterns by Oligonucleotide Microarray of Basal versus Lipopolysaccharide-Activated Monocytes from Cord Blood versus Adult Peripheral Blood J. Immunol., May 15, 2004; 172(10): 5870 - 5879. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. QUARANTA, B. MATTIOLI, F. SPADARO, E. STRAFACE, L. GIORDANI, C. RAMONI, W. MALORNI, and M. VIORA HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells FASEB J, November 1, 2003; 17(14): 2025 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Lindner, M. A. Kharfan-Dabaja, E. Ayala, D. Kolonias, L. M. Carlson, Y. Beazer-Barclay, U. Scherf, J. H. Hnatyszyn, and K. P. Lee Induced Dendritic Cell Differentiation of Chronic Myeloid Leukemia Blasts Is Associated with Down-Regulation of BCR-ABL J. Immunol., August 15, 2003; 171(4): 1780 - 1791. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wachter, M. Averbeck, H. Hara, J. P. Tesmann, J. C. Simon, C. C. Termeer, and R. W. Denfeld Induction of CD4+ T Cell Apoptosis as a Consequence of Impaired Cytoskeletal Rearrangement in UVB-Irradiated Dendritic Cells J. Immunol., July 15, 2003; 171(2): 776 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-L. Tharaux, R. C. Bukoski, P. N. Rocha, S. D. Crowley, P. Ruiz, C. Nataraj, D. N. Howell, K. Kaibuchi, R. F. Spurney, and T. M. Coffman Rho Kinase Promotes Alloimmune Responses by Regulating the Proliferation and Structure of T Cells J. Immunol., July 1, 2003; 171(1): 96 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yanagawa and K. Onoe CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities Blood, June 15, 2003; 101(12): 4923 - 4929. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Senga, S. Iwamoto, T. Yoshida, T. Yokota, K. Adachi, E. Azuma, M. Hamaguchi, and T. Iwamoto LSSIG is a novel murine leukocyte-specific GPCR that is induced by the activation of STAT3 Blood, February 1, 2003; 101(3): 1185 - 1187. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |